> Dear allstaters,
>
> please find attached the latest contract vacancy for you to review;
>
> TITLE: Statistician - Phase II CNS Trials (6 months+)
>
> ROLE: Essential; educated to degree level in biostatistics / statistics /
> related subject, minimum 2 years working as a statistician in the
> pharmaceutical / CRO industries, SAS & clinical reporting. Desirable; any
> specific therapeutic knowledge of CNS. Working for my client you will work
> closely with an assistant SAS programmer reporting on adverse events &
> cleaning a side effects database. This is an exclusive role and interview
> times are booked for a potential immediate start, although they can wait
> for notice periods.
>
> LOCATION: Europe
> CONTRACT LENGTH: 6 months+
> RATE: Dependant on experience
> START DATE: ASAP, but they will wait for notice periods
>
> If you interested in this role please feel free to contact me for further
> details at the earliest possible moment.
>
> Regards
>
> James Carrera
> European Contracts Manager
> Pharmaceutical, Healthcare & CRO division.
> 1st IT People
> Tel: +44 (0) 207 940 3900
> Fax: +44 (0) 207 886 8161
> mailto:[log in to unmask]
> www.1st-itpeople.com
>
> Offices in UK, Switzerland, The Netherlands & Hong Kong
> This email is confidential and intended solely for the use of the
> individual to whom it is addressed. Any views or opinions presented are
> solely those of the author and do not represent those of the company from
> which the email was sent. If you are not the intended recipient, be
> advised that you have received this e-mail in error and that any use,
> dissemination forwarding, printing or copying of this e-mail is strictly
> prohibited. While every effort has been made to scan this e-mail, we can
> not accept any responsibility for loss of business or damage caused
> arising from this e-mail.
>
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|